Back to Results
First PageMeta Content
Medicine / HIV/AIDS / Microbicides / Dendrimer / Supramolecular chemistry / Vaginal microbicide / Sexually transmitted disease / HIV / AIDS / Sexually transmitted diseases and infections / Health / Microbiology


PLEASE ADJUST SPINE ACCORDINGLY Starpharma annual report 2001 Starpharma annual report 2001
Add to Reading List

Document Date: 2011-06-26 22:20:41

Open Document

File Size: 343,83 KB

Share Result on Facebook

City

Vancouver / New York / Sydney / Leuven / Prague / Melbourne / /

Company

Australian Stock Exchange / Dendritic Nanotechnologies Limited / Starpharma Pooled Development Limited / Report Starpharma Annual Report 7 Developing Drug Solutions / Leading Position 10 Dendritic Nanotechnologies Limited / Canada Viridae Clinical Sciences Inc / /

Continent

Europe / /

Country

Australia / United States / /

Currency

USD / /

Event

FDA Phase / Patent Issuance / /

Facility

University Medical Centre Project / USA University of Alabama / Czech Republic Institute of Organic Chemistry / Biomolecular Research Institute / Australia University of Queensland Project / USA Fox Chase Institute / USA University of Utah Virology Laboratory Project / Baker Medical Research Institute / University Project / /

IndustryTerm

microbicidal products / receptor-site / platform technology / spectrum vaginal microbicide product / prevention of sexually transmitted diseases / nanomedicine products / dendrimer-based pharmaceuticals / biotechnology stocks / pharmaceuticals / microbicide product / manufacturing / antiviral applications / dendrimer technology / scientific and pharmaceutical communities / vaginal microbicide product / microbicidal product / / rapid product / pharmaceutical applications / research / disease applications / treatment of major human diseases / electronics / pharmaceutical products / /

MedicalCondition

HIV / hepatitis B / Targets Starpharma’s priority disease / human diseases / hepatitis / SPL7013 preventing HIV infection / Cancer / malaria / HPV / Hepatitis B/Liver Cancer / STDs / diseases / AIDS / HIV/AIDS / Dengue / herpes simplex virus / sexually transmitted diseases / warts / genital herpes / certain diseases / herpes / genital warts / Anti-Toxins Bacterial Entero-toxins Venoms Exotic Viruses Ebola Dengue SexuallyTransmitted Diseases HIV Herpes Simplex Virus Genital Warts / influenza / HIV infection / Major Diseases / disease / Ebola / patent coverage infections / hepatitis B. In / /

MedicalTreatment

dendrimer / dendrimers / /

Organization

Baker Medical Research Institute in Melbourne / Australia University / Cornell University / Czech Republic Institute of Organic Chemistry / University of Utah / Biomolecular Research Institute / U.S. Congress / U.S. federal government / University of Queensland / United States Army / Department of Applied Biology / Georgetown University / National Institute of Health / Pooled Development Fund / Baylor University / USA Fox Chase Institute / U.S. Patent Office / U.S. Food and Drug Administration / University of Alabama / USA University / /

Person

Barry Matthews / Tim Grogan / John Raff / Donald A. Tomalia / Exotic Viruses / Tom McCarthy / Richard Oliver / George Holan / Chris Virgona / /

Position

Preclinical Development Manager / CEO / Major / pharmaceutical companies CEO / Major Commercial Development Opportunities / Head Office / Angiogenesis/Toxicology/ General / Consultant / market leader / Chairman / /

Product

Preclinical / Starpharma / Global Research Network / vaginal / Humans / /

ProvinceOrState

Ohio / Alabama / Utah / Texas / Queensland / Maryland / Pennsylvania / /

RadioStation

Richard Oliver AM / /

Technology

drug discovery / dendrimer technology / biotechnology / platform technology / drug development / /

SocialTag